Mechanisms of T cell exhaustion guiding next-generation immunotherapy

Zajac, 1998, Viral immune evasion due to persistence of activated T cells without effector function, J. Exp. Med., 188, 2205, 10.1084/jem.188.12.2205 Zinkernagel, 1993, Effector T-cell induction and T-cell memory versus peripheral deletion of T cells, Immunol. Rev., 133, 199, 10.1111/j.1600-065X.1993.tb01517.x Wherry, 2004, Antigen-independent memory CD8 T cells do not develop during chronic viral infection, Proc. Natl. Acad. Sci. U. S. A., 101, 16004, 10.1073/pnas.0407192101 Utzschneider, 2013, T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion, Nat. Immunol., 14, 603, 10.1038/ni.2606 Shin, 2007, CD8 T cell dysfunction during chronic viral infection, Curr. Opin. Immunol., 19, 408, 10.1016/j.coi.2007.06.004 Man, 2017, Transcription factor IRF4 promotes CD8+ T cell exhaustion and limits the development of memory-like T cells during chronic infection, Immunity, 47, 1129, 10.1016/j.immuni.2017.11.021 Martinez, 2015, The transcription factor NFAT promotes exhaustion of activated CD8(+) T cells, Immunity, 42, 265, 10.1016/j.immuni.2015.01.006 Alfei, 2019, TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection, Nature, 571, 265, 10.1038/s41586-019-1326-9 Khan, 2019, TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion, Nature, 571, 211, 10.1038/s41586-019-1325-x Scott, 2019, TOX is a critical regulator of tumour-specific T cell differentiation, Nature, 571, 270, 10.1038/s41586-019-1324-y Frias, 2021, Epigenetic regulation of T cell adaptive immunity, Immunol. Rev., 300, 9, 10.1111/imr.12943 Shields, 2017, Indicators of responsiveness to immune checkpoint inhibitors, Sci. Rep., 7, 807, 10.1038/s41598-017-01000-2 Morad, 2021, Hallmarks of response, resistance, and toxicity to immune checkpoint blockade, Cell, 184, 5309, 10.1016/j.cell.2021.09.020 Ghoneim, 2017, De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation, Cell, 170, 142, 10.1016/j.cell.2017.06.007 Pauken, 2016, Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade, Science, 354, 1160, 10.1126/science.aaf2807 Liu, 2021, LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade, Nat. Commun., 12, 6831, 10.1038/s41467-021-27179-7 Prinzing, 2021, Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity, Sci. Transl. Med., 13, 10.1126/scitranslmed.abh0272 Abdel-Hakeem, 2021, Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation, Nat. Immunol., 22, 1008, 10.1038/s41590-021-00975-5 Yates, 2021, Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans, Nat. Immunol., 22, 1020, 10.1038/s41590-021-00979-1 Im, 2016, Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy, Nature, 537, 417, 10.1038/nature19330 Brummelman, 2018, High-dimensional single cell analysis identifies stem-like cytotoxic CD8(+) T cells infiltrating human tumors, J. Exp. Med., 215, 2520, 10.1084/jem.20180684 Gettinger, 2018, A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers, Nat. Commun., 9, 3196, 10.1038/s41467-018-05032-8 Utzschneider, 2020, Early precursor T cells establish and propagate T cell exhaustion in chronic infection, Nat. Immunol., 21, 1256, 10.1038/s41590-020-0760-z Sade-Feldman, 2018, Defining T cell states associated with response to checkpoint immunotherapy in melanoma, Cell, 175, 998, 10.1016/j.cell.2018.10.038 Hudson, 2019, Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1+ stem-like CD8+ T cells during chronic infection, Immunity, 51, 1043, 10.1016/j.immuni.2019.11.002 Pace, 2018, The epigenetic control of stemness in CD8+ T cell fate commitment, Science, 359, 177, 10.1126/science.aah6499 Lee, 2021, Tet2 inactivation enhances the antitumor activity of tumor-infiltrating lymphocytes, Cancer Res., 81, 1965, 10.1158/0008-5472.CAN-20-3213 Henning, 2018, Epigenetic control of CD8+ T cell differentiation, Nat. Rev. Immunol., 18, 340, 10.1038/nri.2017.146 Zhong, 2022, Hierarchical regulation of the resting and activated T cell epigenome by major transcription factor families, Nat. Immunol., 23, 122, 10.1038/s41590-021-01086-x Abdelsamed, 2020, Beta cell-specific CD8+ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes, Nat. Immunol., 21, 578, 10.1038/s41590-020-0633-5 Zebley, 2021, CD19-CAR T cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia, Cell Rep., 37, 10.1016/j.celrep.2021.110079 Gerhard, 2021, Tumor-infiltrating dendritic cell states are conserved across solid human cancers, J. Exp. Med., 218, 10.1084/jem.20200264 Di Pilato, 2021, CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment, Cell, 184, 4512, 10.1016/j.cell.2021.07.015 Flynn, 2014, Stem memory T cells (TSCM)—their role in cancer and HIV immunotherapies, Clin. Transl. Immunol., 3, 10.1038/cti.2014.16 Gattinoni, 2011, A human memory T cell subset with stem cell-like properties, Nat. Med., 17, 1290, 10.1038/nm.2446 Sabatino, 2016, Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies, Blood, 128, 519, 10.1182/blood-2015-11-683847 Klebanoff, 2012, Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?, J. Immunother., 35, 651, 10.1097/CJI.0b013e31827806e6 Chen, 2021, Integrative bulk and single-cell profiling of pre-manufacture T-cell populations reveals factors mediating long-term persistence of CAR T-cell therapy, Cancer Discov., 11, 2186, 10.1158/2159-8290.CD-20-1677 Qin, 2018, Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptor, Blood, 132, 1899, 10.1182/blood-2017-12-815548 Palma, 2017, T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers, Haematologica, 102, 562, 10.3324/haematol.2016.151100 Sommermeyer, 2016, Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo, Leukemia, 30, 492, 10.1038/leu.2015.247 Fraietta, 2018, Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia, Nat. Med., 24, 563, 10.1038/s41591-018-0010-1 Summers, 2021, Hematopoietic cell transplantation after CD19 chimeric antigen receptor T cell-induced acute lymphoblastic lymphoma remission confers a leukemia-free survival advantage, Transplant. Cell. Ther., 28, 21, 10.1016/j.jtct.2021.10.003 Lynn, 2019, c-Jun overexpression in CAR T cells induces exhaustion resistance, Nature, 576, 293, 10.1038/s41586-019-1805-z Seo, 2021, BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells, Nat. Immunol., 22, 983, 10.1038/s41590-021-00964-8 Wei, 2019, Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy, Nature, 576, 471, 10.1038/s41586-019-1821-z Shifrut, 2018, Genome-wide CRISPR screens in primary human T cells reveal key regulators of immune function, Cell, 175, 1958, 10.1016/j.cell.2018.10.024 Fraietta, 2018, Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells, Nature, 558, 307, 10.1038/s41586-018-0178-z Wang, 2021, Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming, Nat. Commun., 12, 409, 10.1038/s41467-020-20696-x Ley, 2010, DNMT3A mutations in acute myeloid leukemia, N. Engl. J. Med., 363, 2424, 10.1056/NEJMoa1005143 Kramer, 2017, Dnmt3a regulates T-cell development and suppresses T-ALL transformation, Leukemia, 31, 2479, 10.1038/leu.2017.89 Tovy, 2020, Tissue-biased expansion of DNMT3A-mutant clones in a mosaic individual is associated with conserved epigenetic erosion, Cell Stem Cell, 27, 326, 10.1016/j.stem.2020.06.018 van den Akker, 2020, Dynamic clonal hematopoiesis and functional T-cell immunity in a supercentenarian, Leukemia, 35, 2125, 10.1038/s41375-020-01086-0 Gibson, 2021, Donor clonal hematopoiesis and recipient outcomes after transplantation, J. Clin. Oncol., 40, 189, 10.1200/JCO.21.02286 Zebley, 2020, Rewriting history: epigenetic reprogramming of CD8+ T cell differentiation to enhance immunotherapy, Trends Immunol., 41, 665, 10.1016/j.it.2020.06.008 Topper, 2020, The emerging role of epigenetic therapeutics in immuno-oncology, Nat. Rev. Clin. Oncol., 17, 75, 10.1038/s41571-019-0266-5 Zebley, 2021, Proinflammatory cytokines promote TET2-mediated DNA demethylation during CD8 T cell effector differentiation, Cell Rep., 37, 10.1016/j.celrep.2021.109796